샘플 요청 목록

 카트 문의
시장보고서
상품코드
2132536

RNAi 기술 시장 규모, 점유율 및 동향 분석 보고서 : 제품 및 서비스별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End Use, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ￦ 8,152,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ￦ 9,522,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ￦ 12,262,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

RNAi 기술 시장 요약

세계의 RNAi 기술 시장 규모는 2025년에 33억 달러로 평가되며, 2026년 37억 달러에서 2033년까지 95억 달러로 확대하며, 2026-2033년까지 연평균 성장률(CAGR)은 14.6%에 달할 것으로 예측됩니다.

북미는 세계 시장을 주도하고 있으며, 2025년에는 38.3%라는 가장 큰 매출 점유율을 차지했습니다. 이 시장의 성장은 전 세계에서 자가면역 질환, 희귀 질환 및 암의 유병률이 증가하고 있는 데 기인한 것으로 보입니다.

자주 묻는 질문

  • RNAi 기술 시장의 규모는 어떻게 변화할 것으로 예상되나요?
  • RNAi 기술 시장에서 북미의 매출 점유율은 어떻게 되나요?
  • RNAi 기술 시장의 성장은 어떤 요인에 의해 영향을 받나요?

목차

제1장 조사 방법과 범위

제2장 개요

제3장 시장 : 변수, 동향, 범위

제4장 제품·서비스별 비즈니스 분석

제5장 용도별 비즈니스 분석

제6장 최종 용도별 비즈니스 분석

제7장 지역별 비즈니스 분석

제8장 경쟁 구도

KSA 26.09.30

RNAi Technology Market Summary

The global RNAi technology market size was valued at USD 3.3 billion in 2025 and is projected to grow from USD 3.7 billion in 2026 to USD 9.5 billion by 2033, at a CAGR of 14.6% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 38.3% in 2025. The market growth can be attributed to the increasing prevalence of autoimmune diseases, rare disorders, and cancer across the globe.

Global RNAi Technology Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global RNAi technology market report based on product & service, application, end use, and region:

  • Product & Service Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Products
    • siRNA products
    • miRNA products
    • Others
  • Services
  • Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Drug Discovery & Development
    • Neurology
    • Oncology
    • Infectious Diseases
    • Metabolic Diseases
    • Others
  • Functional Genomics
  • Others
  • End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • CROs & CMOs
  • Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Products & Service Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. List of Secondary Sources
    • 1.9.3. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements in RNAi Techniques
      • 3.2.1.2. Increasing Application of RNAi Technology in Research and Medicine
      • 3.2.1.3. Growing Demand for Precision Therapeutics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Development and Manufacturing Costs
      • 3.2.2.2. Challenges Associated with Efficient RNAi Delivery Systems
      • 3.2.2.3. Off-Target Effects and Safety Concerns
    • 3.2.3. Market Opportunities Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTLE Analysis

Chapter 4. Product & Service Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. RNAi Technology Market: Product & Service Movement Analysis
  • 4.3. Products
    • 4.3.1. Products Market, 2021-2033 (USD Million/Billion)
    • 4.3.2. siRNA Products
      • 4.3.2.1. siRNA Products Market, 2021-2033 (USD Million/Billion)
    • 4.3.3. miRNA Products
      • 4.3.3.1. miRNA Products Market, 2021-2033 (USD Million/Billion)
    • 4.3.4. Others
      • 4.3.4.1. Others Market, 2021-2033 (USD Million/Billion)
  • 4.4. Services
    • 4.4.1. Services Market, 2021-2033 (USD Million/Billion)

Chapter 5. Application Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. RNAi Technology Market: Application Movement Analysis
  • 5.3. Drug Discovery & Development
    • 5.3.1. Drug Discovery & Development Market, 2021-2033 (USD Million/Billion)
    • 5.3.2. Neurology
      • 5.3.2.1. Neurology Market, 2021-2033 (USD Million/Billion)
    • 5.3.3. Oncology
      • 5.3.3.1. Oncology Market, 2021-2033 (USD Million/Billion)
    • 5.3.4. Infectious Diseases
      • 5.3.4.1. Infectious Diseases Market, 2021-2033 (USD Million/Billion)
    • 5.3.5. Metabolic Diseases
      • 5.3.5.1. Metabolic Diseases Market, 2021-2033 (USD Million/Billion)
    • 5.3.6. Others
      • 5.3.6.1. Others Market, 2021-2033 (USD Million/Billion)
  • 5.4. Functional Genomics
    • 5.4.1. Functional Genomics Market, 2021-2033 (USD Million/Billion)
  • 5.5. Others
    • 5.5.1. Others Market, 2021-2033 (USD Million/Billion)

Chapter 6. End Use Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. RNAi Technology Market: End Use Movement Analysis
  • 6.3. Pharmaceutical & Biotechnology Companies
    • 6.3.1. Pharmaceutical & Biotechnology Companies Market, 2021-2033 (USD Million/Billion)
  • 6.4. Academic & Research Institutes
    • 6.4.1. Academic & Research Institutes Market, 2021-2033 (USD Million/Billion)
  • 6.5. CROs & CMOs
    • 6.5.1. CROs & CMOs Market, 2021-2033 (USD Million/Billion)

Chapter 7. Regional Business Analysis

  • 7.1. RNAi Technology Market Share By Region, 2025 & 2033
  • 7.2. North America
    • 7.2.1. North America RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Mexico RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
  • 7.3. Europe
    • 7.3.1. Europe RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Thailand RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
  • 7.5. Latin America
    • 7.5.1. Latin America RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Argentina RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
  • 7.6. MEA
    • 7.6.1. MEA RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait RNAi Technology Market, 2021 - 2033 (USD Million/Billion)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share/ Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Creative Biolabs
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Revvity
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Promega Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. OriGene Technologies, Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Altogen Biosystems
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Danaher
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Bioneer Corporation
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기